Showing results (91-100 of 729) with videos related to
Sort By:
Pageof 73
Journal of Affective Disorders|August 4, 2012
Cardiovascular diseases do not influence the mental health outcome of older men with depression over 6 yearsOsvaldo P Almeida, Helman Alfonso, Bu B Yeap, et al.BMC Geriatrics|September 6, 2013
The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trialJohn Gommans, Qilong Yi, John W Eikelboom, et al.Archives of General Psychiatry|November 5, 2008
Homocysteine and depression in later lifeOsvaldo P Almeida, Kieran McCaul, Graeme J Hankey, et al.Stroke|October 30, 2020
Stroke Prevention in Older Adults: Recent AdvancesJ David Spence, M Reza Azarpazhooh, Susanna C Larsson, et al.The Cochrane Database of Systematic Reviews|October 13, 2009
Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patientsCathie Lm Sudlow, Gillian Mason, James B Maurice, et al.Cardiovascular Ultrasound|January 23, 2008
Ultrasound settings significantly alter arterial lumen and wall thickness measurementsKathleen Potter, Christopher J Reed, Daniel J Green, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 22, 2008
Homocysteine or renal impairment: which is the real cardiovascular risk factor?Kathleen Potter, Graeme J Hankey, Daniel J Green, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 23, 2023
Pre-treatment re-bleeding following aneurysmal subarachnoid hemorrhage: A systematic review of published prediction models with risk of bias and clinical applicability assessmentArosha S Dissanayake, Kwok M Ho, Timothy J Phillips, et al.Trials|August 21, 2015
The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trialsGillian Mead, Maree L Hackett, Erik Lundström, et al.Journal of HIV Therapy|May 8, 2003
Building the best regimen for highly treatment-experienced patientsMark R NelsonPageof 73